This site is intended for healthcare professionals
Journals
  • Home
  • /
  • Journals
  • /
  • Hepatitis
  • /
  • Pregenomic RNA: How to assist the management of ch...
Journal

Pregenomic RNA: How to assist the management of chronic hepatitis B?

Read time: 1 mins
Published:1st Jul 2019
Author: Wu Y, Wen J, Xiao W, Zhang B.
Availability: Pay for access, or by subscription
Ref.:Rev Med Virol. 2019;29(4):e2051.
DOI:10.1002/rmv.2051

Pregenomic RNA (pgRNA) is an emerging serological marker for chronic hepatitis B virus (HBV) infection. While pgRNA is principally the template for viral proteins and viral DNAs, additional novel functions for the serum pgRNA have recently been described. These results extend for pgRNA a regulatory function in the viral life cycle and potentially a role in pathogenesis. Here, we review the diverse roles of pgRNA in HBV replication and pathogenesis, emphasizing how the unique structure of this RNA is key to its various functions. We focus in particular on the role of HBV pgRNA in guiding antiviral therapy including nucleot(s)ide analog interruption and role as a marker of cure with new curative therapies. We also briefly allude to the emerging niche for new direct-acting or indirect-acting antivirals targeting pgRNA.

 

Read abstract on library site

Access full article